Olutasidenib

Modify Date: 2025-08-25 08:46:29

Olutasidenib Structure
Olutasidenib structure
Common Name Olutasidenib
CAS Number 1887014-12-1 Molecular Weight 354.79
Density N/A Boiling Point N/A
Molecular Formula C18H15ClN4O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Olutasidenib


Olutasidenib is a highly potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 that could be used in the treatment of acute myeloid leukemia.

 Names

Name Olutasidenib

 Olutasidenib Biological Activity

Description Olutasidenib is a highly potent, selective inhibitor of mutant Isocitrate dehydrogenase (IDH)1 that could be used in the treatment of acute myeloid leukemia.
Related Catalog
Target

IDH1[1].

References

[1]. JM Watts, et al. A phase 1 dose escalation study of the IDH1m inhibitor, FT-2102, in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

 Chemical & Physical Properties

Molecular Formula C18H15ClN4O2
Molecular Weight 354.79
InChIKey NEQYWYXGTJDAKR-JTQLQIEISA-N
SMILES CC(Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.